StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by coalbeton Mar 25, 2019 2:51pm

68 Views

Post# 29532822

level 2

GENENEWS LIMITED (CA:GEN)
Size	Bid	Ask	Size
437000	0.150	0.155	327000
95500	0.145	0.160	100000
439500	0.140	0.165	45000
32000	0.135	0.170	106000
139500	0.130	0.175	247000

Previous 10 Trades
Time	Size	Price
14:45:05	10000	0.150
14:45:04	10000	0.150
14:42:49	2000	0.150
14:42:49	8000	0.150
14:42:49	10000	0.150
14:42:49	7000	0.150
14:42:49	5000	0.150
14:42:49	8000	0.150
14:30:15	9000	0.155
14:30:15	500	0.155